Ciongoli Gregory Austin
SEC Form 4 insider trading activity
Ciongoli Gregory Austin has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including RGNX, ATRA, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 27, 2026.
On the most recent filing, Ciongoli Gregory Austin is listed as Director at REGENXBIO Inc. Inside the rolling window, Ciongoli Gregory Austin reported 2 open-market purchases totaling $949K in RGNX and no open-market sales. The largest disclosed transaction in the window is a purchase of 53,407 RGNX shares on Aug 27, 2026, worth $500K.
Companies traded
Other insiders at RGNX
Insider Buying
$949K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ciongoli Gregory Austin made?
Ciongoli Gregory Austin has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including RGNX, ATRA since 2026.
Which companies does Ciongoli Gregory Austin trade?
Ciongoli Gregory Austin has filed SEC Form 4 disclosures for 2 companies, including RGNX, ATRA.
When was Ciongoli Gregory Austin's most recent SEC Form 4 filing?
Ciongoli Gregory Austin's most recent SEC Form 4 filing on Tracefour is dated Aug 27, 2026.
What is Ciongoli Gregory Austin's total buy and sell value in the current window?
Inside the rolling retention window, Ciongoli Gregory Austin bought $949K and sold $0 based on SEC Form 4 filings.
What was Ciongoli Gregory Austin's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 53,407 RGNX shares on 2026-08-27, worth $500K, per SEC Form 4 filings.